Building Competency in Diabetes Education THE ESSENTIALS

BASAL-BOLUS INSULIN THERAPY | 12-104

REFERENCES

1. McGibbon A, Adams L, Ingersoll K, et al. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: Glycemic management in adults with type 1 diabetes. Can J Diabetes 2018;42(Suppl 1):S80-S87. 2. Jones H, Cleave B, Hamilton C, et al. Stages of intensive therapy: Evaluation of a new measurement tool. Can J Diabetes 2006;31:21-9. 3. Beck R, Bergenstal R. Beyond A1C-Standardization of Continuous Glucose Monitoring Reporting: Why it is needed and how it continues to evolve. Diabetes Spectrum 2021 34:102-109. 4. Aleppo G. Clinical Application of Time in Range and other metrics. Diabetes Spectrum 2021 34:109-118. 5. Monnier L, Colette C. Glycemic variability: Should we and can we prevent it? Diabetes Care 2008;31(Suppl 2):S150-S154. 6. Imran SA, Agarwal G, Bajaj HS, et al. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: Targets for glycemic control. Can J Diabetes 2018;42(Suppl 1):S42-S46. 7. Kirkpatrick E, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-90. 8. Delamater AM, Jacobson AM, Anderson B, et al. Psychosocial therapies in diabetes: Report of the psychosocial therapies working group. Diabetes Care 2001;24:1286-92. 9. Robinson DJ, Coons M, Haensel H, et al. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: Diabetes and mental health. Can J Diabetes 2018;42(Suppl 1):S130-S141. 10. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86. 11. Rose M, Burkert U, Scholler G, et al. Determinants of the quality of life of patients with diabetes under intensified insulin therapy. Diabetes Care 1998;21:1876-85. 12. Hoogma RP, Hammond PJ, Gomis R, et al. Continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5-nations trial. Diabetic Medicine 2006;23:141-7. 13. Vervoort G, Goldschmidt HM, van Doorn LG. Nocturnal blood glucose profiles in clients with type 1 diabetes mellitus on multiple (> or = 4) daily insulin injection regimens. Diabetic Medicine 1996;13:794-9.